Ineos Healthcare Limited   Report issue

For profit Phase 3
Founded: Warrington United Kingdom (2002)
Status: Defunct (2010)

Organization Overview

First Clinical Trial
2006
NCT00317694
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Alternative names

INEOS Healthcare Ltd, UK

Active Ingredients

Drugs in Phase 3 Trials (4)

fermagate (4 trials)

iron hydroxide adipate (1 trial)

lanthanum (1 trial)

sevelamer (renagel) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hyperphosphatemia (Phase 3)

Kidney Failure, Chronic (Phase 3)

Renal Insufficiency (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 4